Lisanti Capital Growth’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,650
Closed -$916K 137
2024
Q2
$916K Hold
6,650
0.22% 104
2024
Q1
$917K Sell
6,650
-105
-2% -$14.5K 0.22% 109
2023
Q4
$890K Sell
6,755
-19,875
-75% -$2.62M 0.21% 112
2023
Q3
$3M Buy
26,630
+13,040
+96% +$1.47M 0.47% 83
2023
Q2
$1.28M Buy
+13,590
New +$1.28M 0.18% 128
2023
Q1
Sell
-29,295
Closed -$3.5M 139
2022
Q4
$3.5M Sell
29,295
-58,055
-66% -$6.93M 0.48% 81
2022
Q3
$9.28M Buy
87,350
+31,000
+55% +$3.29M 1.24% 25
2022
Q2
$5.49M Buy
56,350
+14,140
+33% +$1.38M 0.75% 60
2022
Q1
$3.96M Buy
+42,210
New +$3.96M 0.44% 90
2020
Q3
Sell
-15,315
Closed -$1.87M 132
2020
Q2
$1.87M Buy
15,315
+5,620
+58% +$685K 0.38% 87
2020
Q1
$839K Sell
9,695
-741
-7% -$64.1K 0.28% 93
2019
Q4
$1.12M Buy
10,436
+1,366
+15% +$147K 0.3% 97
2019
Q3
$817K Buy
+9,070
New +$817K 0.27% 85
2018
Q4
Sell
-7,120
Closed -$875K 114
2018
Q3
$875K Sell
7,120
-110
-2% -$13.5K 0.3% 95
2018
Q2
$710K Sell
7,230
-3,975
-35% -$390K 0.27% 109
2018
Q1
$929K Buy
11,205
+2,750
+33% +$228K 0.45% 89
2017
Q4
$656K Buy
+8,455
New +$656K 0.38% 93
2016
Q4
Sell
-20,426
Closed -$1.03M 98
2016
Q3
$1.03M Buy
20,426
+8,980
+78% +$455K 1.31% 30
2016
Q2
$520K Sell
11,446
-1,520
-12% -$69.1K 0.78% 60
2016
Q1
$513K Sell
12,966
-12,535
-49% -$496K 0.61% 79
2015
Q4
$1.44M Sell
25,501
-6,599
-21% -$373K 1.52% 22
2015
Q3
$1.28M Sell
32,100
-3,635
-10% -$145K 1.15% 42
2015
Q2
$1.71M Buy
35,735
+18,325
+105% +$875K 1.23% 44
2015
Q1
$691K Buy
+17,410
New +$691K 0.39% 89
2013
Q3
Sell
-144,455
Closed -$2.02M 108
2013
Q2
$2.02M Buy
+144,455
New +$2.02M 0.97% 51